These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 18992247)

  • 21. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival.
    Matos P; Oliveira C; Velho S; Gonçalves V; da Costa LT; Moyer MP; Seruca R; Jordan P
    Gastroenterology; 2008 Sep; 135(3):899-906. PubMed ID: 18602919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
    Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
    Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low expression of reduced folate carrier-1 and folylpolyglutamate synthase correlates with lack of a deleted in colorectal carcinoma mRNA splice variant in normal-appearing mucosa of colorectal carcinoma patients.
    Wettergren Y; Odin E; Nilsson S; Willen R; Carlsson G; Gustavsson B
    Cancer Detect Prev; 2005; 29(4):348-55. PubMed ID: 16122883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased topoisomerase IIalpha expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis.
    Coss A; Tosetto M; Fox EJ; Sapetto-Rebow B; Gorman S; Kennedy BN; Lloyd AT; Hyland JM; O'Donoghue DP; Sheahan K; Leahy DT; Mulcahy HE; O'Sullivan JN
    Cancer Lett; 2009 Apr; 276(2):228-38. PubMed ID: 19111388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of CDK2-AP1 (p12(DOC-1)) expression in human colorectal cancer.
    Yuan Z; Gaba AG; Kent TS; Bennett A; Miller A; Weber TK
    Oncogene; 2005 May; 24(22):3657-68. PubMed ID: 15806176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A del T poly T (8) mutation in the 3' untranslated region (UTR) of the CDK2-AP1 gene is functionally significant causing decreased mRNA stability resulting in decreased CDK2-AP1 expression in human microsatellite unstable (MSI) colorectal cancer (CRC).
    Shin J; Yuan Z; Fordyce K; Sreeramoju P; Kent TS; Kim J; Wang V; Schneyer D; Weber TK
    Surgery; 2007 Aug; 142(2):222-7. PubMed ID: 17689689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of Ki-ras gene mutations within the same tumor using a single tumor crypt in colorectal carcinomas.
    Ishii M; Sugai T; Habano W; Nakamura S
    J Gastroenterol; 2004 Jun; 39(6):544-9. PubMed ID: 15235871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of interleukin (IL)-11 and IL-11 receptor in human colorectal adenocarcinoma: IL-11 up-regulation of the invasive and proliferative activity of human colorectal carcinoma cells.
    Yoshizaki A; Nakayama T; Yamazumi K; Yakata Y; Taba M; Sekine I
    Int J Oncol; 2006 Oct; 29(4):869-76. PubMed ID: 16964382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New strategies for treatment of KRAS mutant metastatic colorectal cancer.
    Prenen H; Tejpar S; Van Cutsem E
    Clin Cancer Res; 2010 Jun; 16(11):2921-6. PubMed ID: 20460490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication.
    Uddin S; Bavi PP; Hussain AR; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Ahmed M; Al-Kuraya KS
    Carcinogenesis; 2009 Nov; 30(11):1832-40. PubMed ID: 19520793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of activator protein-4 in human colorectal cancer with metastasis.
    Cao J; Tang M; Li WL; Xie J; Du H; Tang WB; Wang H; Chen XW; Xiao H; Li Y
    Int J Surg Pathol; 2009 Feb; 17(1):16-21. PubMed ID: 18480385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High frequency of activated K-ras codon 15 mutant in colorectal carcinomas from Taiwanese patients.
    Wang JY; Hsieh JS; Chen FM; Yeh CS; Alexandersen K; Huang TJ; Chen Dc; Lin SR
    Int J Cancer; 2003 Nov; 107(3):387-93. PubMed ID: 14506738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and single nucleotide polymorphisms of kallikrein 10 in colorectal cancer].
    Feng B; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Qu Y; Li JW; Lu AG; Wang ML; Liu BY; Zhu ZG
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):623-7. PubMed ID: 16784657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1.
    Ruan WJ; Lin J; Xu EP; Xu FY; Ma Y; Deng H; Huang Q; Lv BJ; Hu H; Cui J; Di MJ; Dong JK; Lai MD
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):929-32. PubMed ID: 17048309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of RASAL1 as a major tumor suppressor gene in thyroid cancer.
    Liu D; Yang C; Bojdani E; Murugan AK; Xing M
    J Natl Cancer Inst; 2013 Nov; 105(21):1617-27. PubMed ID: 24136889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of colorectal nonpolypoid adenomas: a prospective colonoscopic study and relation with cell kinetics and K-ras mutations.
    Watari J; Saitoh Y; Obara T; Fujiya M; Maemoto A; Ayabe T; Ashida T; Yokota K; Orii Y; Kohgo Y
    Am J Gastroenterol; 2002 Aug; 97(8):2109-15. PubMed ID: 12190185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization.
    Kim MY; Yim SH; Kwon MS; Kim TM; Shin SH; Kang HM; Lee C; Chung YJ
    Gastroenterology; 2006 Dec; 131(6):1913-24. PubMed ID: 17087931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.